Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple sclerosis.
Chronic iron overload induces gender-dependent changes in iron homeostasis, lipid peroxidation and clinical course of experimental autoimmune encephalomyelitis.
Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.
A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitro.
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Striving for Balance Between Caring and Restraint: Young Adults' Experiences with Parental Multiple Sclerosis.
A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.
Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling.
Commentary: Acute Hemorrhagic Leukoencephalitis (Weston-Hurst Syndrome) in a Patient with Relapse-Remitting Multiple Sclerosis.
CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.
Poster 378 Transverse Myelitis Secondary to Infectious Mononucleosis: A Case Report.
Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.
In vivo detection of connectivity between cortical and white matter lesions in early MS.
CIDP presenting as recurrent severe back pain without weakness or sensory loss.
Risk of venous thromboembolism in neuromyelitis optica patients hospitalized for acute relapse.
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
Protein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.
Safety and effectiveness assessment of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A meta-analysis.
The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®.
Theoretical predication of temperature effect on conducting processes in simulated amyotrophic lateral sclerosis at 20-40[Formula: see text]C.
Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorates Long-Term Cognitive Impairments Caused by Neonatal Hypoxia-Ischemia in Rats.
Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation.
Clinical Profiles and Short-Term Outcomes of Acute Disseminated Encephalomyelitis in Adult Chinese Patients.
Interleukin 2 activates brain microvascular endothelial cells resulting in destabilization of adherens junctions.

Pages